Alnylam Pharmaceuticals Correlations

ALNY Stock

USD 244.89 1.91 0.77%

The current 90-days correlation between Alnylam Pharmaceuticals and Incyte is 0.2 (i.e., Modest diversification). The correlation of Alnylam Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Alnylam Pharmaceuticals Correlation With Market

Weak diversification

The correlation between Alnylam Pharmaceuticals and DJI is 0.38 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alnylam Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Alnylam Stock please use our How to Invest in Alnylam Pharmaceuticals guide.

Moving against Alnylam Stock

0.52	RNXT	RenovoRx	Pair Corr
0.47	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.43	KEP	Korea Electric Power	Pair Corr
0.39	VFSWW	VinFast Auto	Pair Corr

Related Correlations Analysis

	PRQR	WVE	BPMC	APLS	INCY	UTHR	RARE	BMRN	SGEN	EXEL
PRQR		0.94	0.19	-0.55	0.67	0.68	-0.66	-0.53	-0.22	0.82	PRQR
WVE	0.94		0.15	-0.74	0.7	0.71	-0.69	-0.7	-0.4	0.81	WVE
BPMC	0.19	0.15		0.09	0.62	0.66	-0.38	-0.02	-0.14	0.53	BPMC
APLS	-0.55	-0.74	0.09		-0.45	-0.44	0.54	0.88	0.61	-0.48	APLS
INCY	0.67	0.7	0.62	-0.45		0.86	-0.72	-0.55	-0.45	0.91	INCY
UTHR	0.68	0.71	0.66	-0.44	0.86		-0.56	-0.47	-0.44	0.8	UTHR
RARE	-0.66	-0.69	-0.38	0.54	-0.72	-0.56		0.59	0.32	-0.82	RARE
BMRN	-0.53	-0.7	-0.02	0.88	-0.55	-0.47	0.59		0.74	-0.62	BMRN
SGEN	-0.22	-0.4	-0.14	0.61	-0.45	-0.44	0.32	0.74		-0.41	SGEN
EXEL	0.82	0.81	0.53	-0.48	0.91	0.8	-0.82	-0.62	-0.41		EXEL
	PRQR	WVE	BPMC	APLS	INCY	UTHR	RARE	BMRN	SGEN	EXEL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

WVE	+ 0.94	PRQR
EXEL	+ 0.91	INCY
BMRN	+ 0.88	APLS
UTHR	+ 0.86	INCY
EXEL	+ 0.82	PRQR
EXEL	+ 0.81	WVE

High negative correlations

EXEL	- 0.82	RARE
APLS	- 0.74	WVE
RARE	- 0.72	INCY
BMRN	- 0.7	WVE
RARE	- 0.69	WVE
RARE	- 0.66	PRQR

Risk-Adjusted Indicators

There is a big difference between Alnylam Stock performing well and Alnylam Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alnylam Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PRQR	5.13	1.10	0.43	0.45	2.36	(9.24)	7.14	(4.95)	129.77
WVE	5.80	1.55	0.47	0.56	3.11	(8.43)	10.86	(6.00)	82.93
BPMC	1.84	(0.12)	(0.03)	0.03	2.61	(1.73)	4.90	(3.62)	14.28
APLS	2.39	(0.40)	0.00	(0.45)	0.00	0.00	4.31	(5.17)	15.97
INCY	1.54	0.09	0.04	0.20	2.01	(1.61)	3.02	(2.70)	20.37
UTHR	1.20	(0.01)	0.00	0.11	1.83	(1.13)	2.89	(3.07)	9.81
RARE	1.51	(0.34)	0.00	(0.37)	0.00	0.00	2.65	(3.20)	8.73
BMRN	1.27	(0.54)	0.00	(1.12)	0.00	0.00	1.42	(3.32)	18.88
SGEN	0.58	(0.04)	0.00	0.33	0.00	0.00	1.02	(0.89)	6.86
EXEL	1.42	0.45	0.29	1.08	0.85	(1.75)	3.14	(1.77)	14.75

Alnylam Pharmaceuticals Corporate Management

Saraswathy Nochur	Equity Diversity	Profile
Indrani JD	Executive Secretary	Profile
Evan Lippman	Chief Officer	Profile
JD Esq	Chief Secretary	Profile
Piyush JD	Chief Officer	Profile
Alfred Boyle	Chief Officer	Profile
Timothy Maines	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC